Navigation Links
Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease
Date:7/7/2008

- Dimebon Significantly Improves Cognition and is Well Tolerated in

Huntington's Disease Patients -

- Findings Warrant Further Development in Huntington's Disease -

- Conference Call Scheduled for Today at 5:00 p.m. EDT -

SAN FRANCISCO, July 7 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced top-line results of a Phase 2 study showing that its investigational drug Dimebon(TM) significantly improved cognitive function in patients with mild-to-moderate Huntington's disease (HD). Cognitive function was significantly improved over placebo (p=0.03) as measured by the Mini-Mental State Examination (MMSE), the cognition scale most widely used by clinicians to assess patients with neurodegenerative diseases. Dimebon-treated patients also demonstrated favorable results on the behavioral component of the United Huntington's Disease Rating Scale (UHDRS), a composite scale measuring several components of HD, but these results did not reach statistical significance.

Dimebon was very well tolerated in this trial. The overall incidence of adverse events was lower in the Dimebon group than in the placebo group, an unusual finding in a clinical study of any drug. This result is consistent with a similar finding from the first pivotal Alzheimer's disease trial in which Dimebon-treated patients had significantly fewer serious adverse events after one year of treatment. Of particular note, Huntington's disease patients treated with Dimebon had fewer falls (9%), a common problem in this patient population that often results in injury and associated health care costs, than did patients on placebo (16%). The most common adverse event in the Dimebon group was headache, which occur
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
2. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
3. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
4. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
7. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
8. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Air Products (NYSE: ... of medical oxygen is vital to any healthcare facility. ... that not only improve the efficiency of its oxygen ... will highlight these systems—including systems for emergency oxygen ... loss—from August 4-5 at the 51 st ...
(Date:7/28/2014)... July 28, 2014  VigeneTech, Inc, in collaboration ... LEGENDplex™ Data Analysis Software, an OEM software solution ...  BioLegend develops and offers varieties of bead-based multi-analyte ... the support of VigeneTech,s data analysis software, FCS ... and easily reported LEGENDplex™ software ...
(Date:7/28/2014)...  UBM Medica US announces that Diagnostic ... imaging professionals, explored the complex situation regarding measuring ... The shift from fee-for-service has left radiology at ... is determined in the new payment model . ... field, who recognized the complexity of the radiologist,s value: ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Diagnostic Imaging Delves into Measuring the Radiologist's Value 2
... drug candidate may help patients with Systemic Lupus Erythematosus ... ... SAN FRANCISCO, Calif., April 29 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ... lupus prone mice and,significantly improved their survival as reported in a ...
... Terumo Heart, Inc. announced,a presentation at ... presentation,entitled "Long Term Circulatory Support with the ... Patients Eligible for,Transplantation: European Experience" was delivered ... for Terumo Heart, Inc., (Photo: ...
Cached Medicine Technology:Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 2Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 3Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 4Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants 2
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 The ... Woods and an incredible field of accompanying PGA TOUR ... winner and golf analyst Notah Begay III for the ... to Turning Stone Resort Casino ’s Atunyote® Golf ... today will include Woods, Jason Dufner, Jimmy Walker, Jonas ...
(Date:7/28/2014)... the July, 2014, issue of the Journal ... Medicine researchers, sheds new light on the risks ... in the treatment of localized, early-stage esophageal cancer. ... while more invasive, provided significantly better outcomes with ... than endoscopic resection, which had a 76 percent ...
(Date:7/28/2014)... decision tree analysis, incorporating Donabedian,s model, is a ... available quality standards, guidelines, recommendations and indicators ... standards for radiation therapy, according to a study ... Practical Radiation Oncology (PRO), the official clinical ... Oncology (ASTRO). , Guidelines, recommendations and indicators may ...
(Date:7/28/2014)... mobile devices are on the cusp of revolutionizing health ... providing everything from cardiac measurements to sonograms. , While ... and control costs, several health law experts say in ... (NEJM) report that more oversight is needed by the ... confidence and safety. Out of some 100,000 mHealth apps ...
(Date:7/28/2014)... 28, 2014 In response to the ... today, BlogHer, The Center for American Progress and The ... Work,” a campaign to raise awareness and promote real ... U.S. The joint initiative was announced on Saturday at ... Judith Warner, Senior Fellow, The Center for American Progress; ...
Breaking Medicine News(10 mins):Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5Health News:Study helps compare risks of treatments for early esophageal cancer 2Health News:Study helps compare risks of treatments for early esophageal cancer 3Health News:Two-step decision tree analysis helps inform updates of RT best practices, quality standards 2Health News:Two-step decision tree analysis helps inform updates of RT best practices, quality standards 3Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 4Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 5
... seems to be reaching epidemic proportions, forcing changes in ... are now revamping their fleet of ambulances to cope ... ,Super-sized vehicles have been introduced and new air ... ambulances will now be equipped with heavy-duty stretchers, capable ...
... has approved four new drugs manufactured by the Macleods of ... of the four would be used against some strains of ... these four medicines will reinforce efforts to scale up access ... a statement. ,The medicines are the first TB ...
... While it is well known that genetics and family history ... lifestyle choices which include diet//, exercise and environment, do play ... session of the American College of Cardiology looked at many ... person’s chances of being diagnosed with heart disease. ...
... claim that they can efficiently seek out and kill ... very similar to the Nature's way of distinguishing one ... tumor targeting strategy, presented today (March 25) at the ... harnesses one of the body's natural antibodies and immune ...
... has sought for more organ donations so as to meet ... According to him there is a big gap between the ... ,Statistics reveal that 1.5 million patients need organ transplants each ... In China organs are donated by people after signing voluntary ...
... all mental health units in England and Wales revealed ... This is much against the government’s claim that this ... ,The healthcare commission reports that 55% of in-patients are ... opposite sex. This practice has resulted in an increase ...
Cached Medicine News:Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:Role of Lifestyle Choices in Heart Risks 2Health News:Role of Lifestyle Choices in Heart Risks 3Health News:Tumors Targeted Naturally 2Health News:Tumors Targeted Naturally 3
... innovative Mesh Cathode of the OsteoGen™-M ... and a scaffolding effect designed to ... fracture ends in the management of ... product particularly appropriate for high-risk patients ...
... implanted bone growth stimulator is a useful adjunct ... already planned or when patient compliance may be ... implanted, patients are assured of therapeutic treatment directly ... for up to 6 months. , ,The OsteoGen ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Interference Screw has unique, double-helix ... while limiting veering and divergence. ... abrasion where it is most ... thread enables screws to be ...
Medicine Products: